GLP-1 analogues can cause a condition called pancreatitis
GLP-1R, when activated, initiates downstream signaling effects that lead to an overall decrease in blood glucose levels, including potentiation of insulin secretion, reduced glucagon secretion, and weight loss via satiety induction that results in increased insulin sensitivity (2)
As the use of GLP-1 medications expands, a growing number of individuals report gastrointestinal side effects such as delayed gastric emptying, nausea, and broader shifts in digestive function
The most common question patients ask me is, When can I stop it? says Koliwad
The triple receptor mechanism that makes Retatrutide so effective also means the body cannot easily develop resistance the way it might with single-target medications
What we know: BPC 157 is a synthetic peptide derived from a protein found in the stomach